1. Home
  2. ZSPC vs MDAIW Comparison

ZSPC vs MDAIW Comparison

Compare ZSPC & MDAIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZSPC
  • MDAIW
  • Stock Information
  • Founded
  • ZSPC 2007
  • MDAIW N/A
  • Country
  • ZSPC United States
  • MDAIW United States
  • Employees
  • ZSPC N/A
  • MDAIW 78
  • Industry
  • ZSPC
  • MDAIW Medical/Dental Instruments
  • Sector
  • ZSPC
  • MDAIW Health Care
  • Exchange
  • ZSPC NYSE
  • MDAIW Nasdaq
  • Market Cap
  • ZSPC N/A
  • MDAIW N/A
  • IPO Year
  • ZSPC 2024
  • MDAIW N/A
  • Fundamental
  • Price
  • ZSPC $3.01
  • MDAIW $0.83
  • Analyst Decision
  • ZSPC Strong Buy
  • MDAIW
  • Analyst Count
  • ZSPC 3
  • MDAIW 0
  • Target Price
  • ZSPC $13.33
  • MDAIW N/A
  • AVG Volume (30 Days)
  • ZSPC 95.2K
  • MDAIW 35.6K
  • Earning Date
  • ZSPC 08-15-2025
  • MDAIW 02-27-2025
  • Dividend Yield
  • ZSPC N/A
  • MDAIW N/A
  • EPS Growth
  • ZSPC N/A
  • MDAIW N/A
  • EPS
  • ZSPC 1.05
  • MDAIW N/A
  • Revenue
  • ZSPC $37,016,000.00
  • MDAIW $27,264,000.00
  • Revenue This Year
  • ZSPC $4.08
  • MDAIW N/A
  • Revenue Next Year
  • ZSPC $39.77
  • MDAIW N/A
  • P/E Ratio
  • ZSPC $2.87
  • MDAIW N/A
  • Revenue Growth
  • ZSPC N/A
  • MDAIW 44.52
  • 52 Week Low
  • ZSPC $2.55
  • MDAIW $0.08
  • 52 Week High
  • ZSPC $32.69
  • MDAIW $0.90
  • Technical
  • Relative Strength Index (RSI)
  • ZSPC N/A
  • MDAIW N/A
  • Support Level
  • ZSPC N/A
  • MDAIW N/A
  • Resistance Level
  • ZSPC N/A
  • MDAIW N/A
  • Average True Range (ATR)
  • ZSPC 0.00
  • MDAIW 0.00
  • MACD
  • ZSPC 0.00
  • MDAIW 0.00
  • Stochastic Oscillator
  • ZSPC 0.00
  • MDAIW 0.00

About MDAIW Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: